Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection

Pediatr Infect Dis J. 2005 Aug;24(8):742-3. doi: 10.1097/01.inf.0000172936.20623.fd.

Abstract

We report an 11-year-old girl with acanthosis nigricans that appeared after 4 years of treatment with didanosine, stavudine and amprenavir. Laboratory studies showed hyperglycemia, hyperinsulinemia and hypertriglyceridemia. Withdrawal of amprenavir resulted in disappearance of acanthosis nigricans and improvement of metabolic abnormalities.

Publication types

  • Case Reports

MeSH terms

  • Acanthosis Nigricans / chemically induced*
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Child
  • Female
  • HIV Infections / drug therapy*
  • Humans